Veracyte Profit Margin

The latest profit margin for VCYT is 20.37% as of June 2026. That compares with 5.5% in the prior-year period — up 270.7% year over year. That is above the Healthcare sector average of 14.41%. Investors often review this figure alongside Veracyte's historical trend and sector peers before judging valuation or financial health.

Over the past year, VCYT's profit margin moved from 5.5% to 20.37% — a 270.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Veracyte's valuation or profitability profile.

Against Healthcare companies, VCYT currently prints 20.37% for profit margin, while the sector average sits near 14.41%. That is roughly 41.3% above the sector mean. Large gaps often invite a closer look at Veracyte's growth, margins, and balance sheet.

Profit Margin shows how effectively Veracyte converts resources into returns. At 20.37%, VCYT may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 5.5% in the prior-year period — up 270.7% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting VCYT's profit margin (20.37%), review year-over-year change from 5.5%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.